This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Oxypharma Ab. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Robert Engqvist: Innovator in Indoloquinoxalines
Introduction
Robert Engqvist is a notable inventor based in Saltsjöbaden, Sweden. He has made significant contributions to the field of chemistry, particularly with his innovative work on alkyl substituted indoloquinoxalines. His research has led to the development of novel substituted indoloquinoxalines, which hold potential applications in various industries.
Latest Patents
Engqvist holds 1 patent for his invention related to alkyl substituted indoloquinoxalines. This patent showcases his expertise in creating new chemical compounds that could be beneficial for future research and applications.
Career Highlights
Throughout his career, Robert Engqvist has worked with several prominent companies, including Oxypharma AB and Vironova AB. His experience in these organizations has allowed him to refine his skills and contribute to important projects in the pharmaceutical and biotechnology sectors.
Collaborations
Engqvist has collaborated with notable professionals in his field, including Ulf Björklund and Jan Bergman. These partnerships have enriched his work and expanded the impact of his inventions.
Conclusion
Robert Engqvist is a distinguished inventor whose work on indoloquinoxalines exemplifies innovation in chemistry. His contributions continue to influence the scientific community and pave the way for future advancements.